These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 11732406

  • 1. [A new antibiotic against respiratory tract infections. More power against pneumococci].
    MMW Fortschr Med; 2001 Nov 01; 143(44):59. PubMed ID: 11732406
    [No Abstract] [Full Text] [Related]

  • 2. [Pharmacodynamic assessment of antibiotic sensitivity of Streptococcus pneumoniae].
    Soriano F.
    Med Clin (Barc); 1999 Jun 26; 113(3):103-8. PubMed ID: 10464745
    [No Abstract] [Full Text] [Related]

  • 3. Community-acquired respiratory tract infections caused by resistant pneumococci: clinical and bacteriological efficacy of the ketolide telithromycin.
    Fogarty CM, Kohno S, Buchanan P, Aubier M, Baz M.
    J Antimicrob Chemother; 2003 Apr 26; 51(4):947-55. PubMed ID: 12654763
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Activity of telithromycin against penicillin-resistant Streptococcus pneumoniae isolates recovered from French children with invasive and noninvasive infections.
    Bingen E, Doit C, Loukil C, Brahimi N, Bidet P, Deforche D, Geslin P.
    Antimicrob Agents Chemother; 2003 Jul 26; 47(7):2345-7. PubMed ID: 12821495
    [Abstract] [Full Text] [Related]

  • 7. [Resistance of respiratory tract infection agents is still increasing. Is its time for new antibiotic strategies?].
    MMW Fortschr Med; 2003 Feb 27; 145(9):55. PubMed ID: 12666535
    [No Abstract] [Full Text] [Related]

  • 8. In vitro activity of the investigational ketolide cethromycin against macrolide- and penicillin-resistant Streptococcus pneumoniae: review of the 1998 to 2006 Canadian Respiratory Organism Susceptibility Study (CROSS).
    Wierzbowski AK, Karlowsky JA, Hoban DJ, Zhanel GG.
    J Antimicrob Chemother; 2009 Mar 27; 63(3):620-2. PubMed ID: 19151038
    [No Abstract] [Full Text] [Related]

  • 9. The clinical impact of macrolide resistance in pneumococcal respiratory infections.
    Garau J.
    Int J Antimicrob Agents; 2001 Mar 27; 18 Suppl 1():S33-8. PubMed ID: 11574193
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Beta-lactamase producers and other bacteria: which ones to take into consideration and when? The viewpoint of the pneumologist].
    Poirier R.
    Presse Med; 1998 Sep 27; 27 Suppl 4():14-5. PubMed ID: 9798478
    [No Abstract] [Full Text] [Related]

  • 12. Resistant pneumococcal infections.
    Koornhof HJ, Jacobs MR.
    Compr Ther; 1979 May 27; 5(5):69-74. PubMed ID: 37022
    [No Abstract] [Full Text] [Related]

  • 13. Streptococcus pneumoniae: does antimicrobial resistance matter?
    Lynch JP, Zhanel GG.
    Semin Respir Crit Care Med; 2009 Apr 27; 30(2):210-38. PubMed ID: 19296420
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Macrolide antibiotics: Streptococcus pneumoniae and Haemophilus influenzae].
    Soriano F, Fernández-Roblas R.
    Enferm Infecc Microbiol Clin; 1996 Oct 27; 14(8):503-4. PubMed ID: 9011211
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Telithromycin (Ketek) for respiratory infections.
    Med Lett Drugs Ther; 2004 Aug 16; 46(1189):66-8. PubMed ID: 15314586
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.